Skip to main content
Private placement could bring in $2.2M for Biocept

A private placement of common stock and warrants involving Hong Kong-based investment group Ally Bridge LB Healthcare Master Fund could pull in $2.2 million for Biocept. Strategic options are also being discussed by the company and Ally Bridge's Chinese affiliate for leveraging the liquid biopsy platform of Biocept in China.

Full Story: